Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2001

View Archived Issues

Novartis highlights significant events during first half of 2001

Long-term outcome in patients with severe PH receiving continuous s.c. UT-15

Oxovanadium compound shows promising activity against tumor growth and metastasis

Piperidine urea-based compounds selective for human beta3-adrenoceptors

Advance in the design of anticancer G-quadruplex ligands reported at ACS meeting

Selective inhibitors of human iNOS: SAR in a series of 2-iminopyrrolidine amino acids

Xefo introduced by CeNeS in U.K.

Pariet receives E.U. clearance for treatment of symptomatic GERD

Major European launch announced for new CLL therapy

Cialis NDA accepted for FDA review

GeneData and diaDexus establish functional genomic data analysis collaboration

Emerging pharmaceutical company announces name change

Synthetic SOD/catalase mimetic may prove useful in sideroblastic anemia

Important new information on heart failure now available from Prous Science

Pharmacyclics reports interim phase I results for Antrin photoangioplasty for CAD

Potential of darusentan in CHF, hypertension supported by clinical trial results

Positive preliminary phase II data reported for Stressgen's HspE7

Z-350 may reduce prostate growth without other hormonal effects

Pfizer NK1 antagonists particularly useful in neovascularization-associated conditions

Modulators of delta opioid receptors and potential uses thereof described by Ortho-McNeil

SCRAS patents new series of somatostatin receptor ligands

Recent patent covers new oxazolidinone antibacterials discovered at Pharmacia

NK1 antagonist HSP-117 active in purported rat model of emesis -- cisplatin-induced pica

Selective inhibitors of nNOS claimed by AstraZeneca for CNS disorders

Byk Gulden presents new alkynyl tryptase inhibitors

AltaRex completes primary analysis of OvaRex clinical trial

Org-30659 comparable to desogestrel for effects on ovarian function

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...